The South African Health Products Regulatory Authority (SAHPRA) has issued a crucial warning regarding products containing zinc picolinate and selenium that are being marketed for children, reports Cape {town} Etc.
In recent evaluations, SAHPRA has determined that both zinc picolinate, a zinc source, and selenium are not permitted in health supplements designed for individuals under 18 years of age.
The authority’s findings, detailed in their guidelines, underscore the potential health risks posed by these ingredients when consumed by children.
According to health experts, zinc picolinate can cause a range of adverse effects, including indigestion, diarrhoea, headaches, nausea, and vomiting.
The unpredictability of zinc absorption from this source further heightens the risk of these side effects, making it an unsuitable option for children’s elemental zinc supplementation.
Conversely, while selenium is essential for children’s growth, excessive intake can lead to serious adverse outcomes.
This risk is especially pronounced given the varying dietary selenium levels among different demographic groups. Although selenium supplementation may be necessary under specific conditions, such as in food-restricted environments, careless administration in general supplements can lead to harmful overdoses.
Many of the products currently available in stores are marketed as ‘immune boosters,’ and are typically indicated for treating ailments such as colds, flu, diarrhoea, and other skin-related conditions categorising them as medicines that require registration with SAHPRA.
Cape {town} Etc Discount Alert! Unlock Cape Town’s best experiences for half the price! From unforgettable adventures to hidden gems and mouthwatering restaurants, these limited-time deals won’t last long. Snag your discount before they’re gone!
In a decisive action, SAHPRA has clarified that any medicinal product containing zinc picolinate or selenium intended for children must be classified as a Category A medicine under the Medicines and Related Substances Act.
As a result, these products must be registered with SAHPRA, and any item sold as a Category D (complementary) medicine is deemed illegal.
Effective immediately, SAHPRA mandates that all such products are to be withdrawn from shelves within six months. Health professionals are urged to stop distributing, selling, or dispensing these items to ensure the safety of children across South Africa.
Parents and guardians are encouraged to return any product containing zinc picolinate or selenium intended for children to their local pharmacies or distributors.
In addition, public and healthcare professionals are reminded to report any adverse effects experienced following the use of these health products via the Med Safety App, contributing vital information to support ongoing safety monitoring.
Be the first to know – Join our WhatsApp Channel for content worth tapping into! Click here to join!
Also read:
Picture: SAHPRA
